Search Media Items

Introduction, Update on Effectiveness and Impact of PCV13 use among U.S. Children, and GRADE for 3-dose PCV13 schedules. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at pneumococcal conjugate vaccine, PCV13, PC13 use, PC13 schedules, GRADE

Considerations for a 3-dose PCV13 schedule for infants. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=307770b7a23d726d6ba2ea498c9b7e8f20140410083023341

Introduction and ACIP Japanese Encephalitis (JE) and Yellow Fever (YF) Vaccines Work Group. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=afb40b9f202e2aca59c472d088e9e2b820140410084424084

Vaccine supply update. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=daf8c9cb272b83789e80a0cb30ee886220140410084253428

Agency updates. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=78f6b551bda41705c808f4acdb8e027820140410090441176

General Recommendations on Immunization Storage and Handling of Immunobiologics, and Storage and handling. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=f23197a4c24f705d5d808df7088b914920140410091148154

Introduction, Enhanced Surveillance of Tdap Safety in Pregnancy in the Vaccine Adverse Event Reporting System (VAERS), and Tdap during pregnancy, safety and coverage data from the Vaccine Safety Datalink (VSD). Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=ca0dfbe59a3e15a6958f42aaa46b8caa20140410092723070

Smallpox Vaccine Work Group Introduction, and Use of ACAM2000 Smallpox Vaccine in Laboratory and Healthcare Personnel. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=fc97650f879e5a10b1a4220e1bbcf71f20140410093028304

Global health measures and mid-decade goals/Decade of the vaccine and the global vaccine action plan/SAGE/WHO vaccine recommendations -- 2010 to present/Current SAGE working groups and topics under consideration by SAGE presented by Dr. J Abramson. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=e65050bf053c25eeaf66b3e36bb03e8820140110114255792

Introduction by Dr. L Rubin. Immunogenicity and safety of MenACWY-CRM by Dr. P Dull. GRADE (grading of evidence) for MenACWY-CRM by Dr. E Briere. Use of MenACWY-CRM for high-risk infants by Dr. J MacNeil. Vaccines for Children by Dr. J Santoli. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod.php?id=c89f64335592b5770af8db0db9db8f6e20140110102952020